Viability parameter | Treatment groups | |||||
Control drug naïve | NaHCO3 | Gentamicin 10 µg/ml | Gentamicin + NaHCO3 | Gentamicin + Cimetidine | Gentamicin + Cimetidine + NaHCO3 | |
Perfusion flow rate (ml/min) | 22.7 (2.50) | 24.8 (3.74) | 29.0 (1.10) | 23.5 (4.87) | 23.7 (7.21) | 28.9 (4.97) |
Urine flow rate (ml/min) | 0.06 (0.03) | 0.12 (0.05) | 0.11 (0.02) | 0.12 (0.01) | 0.08 (0.02) | 0.11 (0.01) |
Urine pH | 7.2 (0.04) | 8.1 (0.58)* | 7.1 (0.17) | 8.1 (0.05)* | 7.0 (0.08) | 8.2 (0.04)* |
GFRa (ml/min/g) | 0.49 (0.15) | 0.51 (0.09) | 0.52 (0.12) | 0.48 (0.04) | 0.43 (0.03) | 0.32 (0.01) |
FRGlucoseb | 0.96 (0.02) | 0.94 (0.01) | 0.97 (0.01) | 0.93 (0.01) | 0.95 (0.01) | 0.88 (0.01)** |
FRSodiumc | 0.94 (0.03) | 0.86 (0.03)* | 0.88 (0.03) | 0.85 (0.02)* | 0.94 (0.03) | 0.84 (0.01)* |
FRChlorided | 0.92 (0.04) | 0.86 (0.06) | 0.85 (0.03) | 0.87 (0.03) | 0.91 (0.01) | 0.85 (0.01) |